Overview

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Status:
Completed

Trial end date:
2018-09-11

Target enrollment:

Participant gender:

Summary

The purpose of the study was to assess the efficacy, safety, and tolerability of mirabegron versus placebo in men with overactive bladder (OAB) symptoms while taking tamsulosin hydrochloride for lower urinary tract symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH).

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Global Development, Inc.

Treatments:

Mirabegron
Tamsulosin